Umbilical Cord Blood Stem Cell Uses: Treatment & Applications

Umbilical cord blood (UCB) is a rich source of hematopoietic stem cells (HSCs) used in transplantation to reconstitute blood and immune systems.

FDA-Approved Indications (Allogeneic & Autologous)

• Hematologic malignancies: Acute leukemias (AML, ALL), chronic leukemias (CML, CLL), lymphomas (Hodgkin, NHL), myelodysplastic syndromes.
• Bone marrow failure: Severe aplastic anemia, Fanconi anemia, Diamond-Blackfan anemia.
• Hemoglobinopathies: Sickle cell disease, β-thalassemia major.
• Primary immunodeficiencies: SCID, Wiskott-Aldrich, CGD, LAD.
• Inherited metabolic disorders: Hurler, Krabbe, metachromatic leukodystrophy, adrenoleukodystrophy.
• Other: Histiocytic disorders, osteopetrosis.

Advantages Over Bone Marrow/Peripheral Blood

• Lower HLA matching stringency (4/6 or 5/6 acceptable) → faster donor search, broader access for diverse patients.
• Lower incidence/severity of chronic GVHD.
• No donor risk (collected post-delivery).
• Cryopreserved—immediately available.

Limitations

• Lower cell dose → slower engraftment, higher early infection risk; limits use in larger adults (double units help).
• No donor lymphocyte infusion (DLI) back-up for relapse.
• Not for solid tumors (breast, lung, colon).

Emerging/Investigational Uses

• Regenerative medicine: cerebral palsy, autism, HIE, stroke (MSC from cord tissue, not blood).
• Immune modulation: T1D, MS, lupus (early phase).
• Ex vivo expansion (nirocord, omidubicel) to accelerate engraftment.

Banking Options

• Public donation: Free; listed on Be The Match/NMDP; helps any matched patient.
• Private banking: $1,500–$2,500 initial + $150–$300/yr; autologous use probability ~1:2,700.

Cord blood saves lives in hematologic diseases. For solid tumors like lung cancer, it has no proven role. Consult a transplant specialist for guidance.